Short answer · Medically reviewed summary · Last updated: 2026-05-08
Central Core Disease (CCD) is a rare congenital myopathy with an estimated prevalence of approximately 1 in 90,000 to 1 in 200,000 individuals worldwide. Due to the wide spectrum of clinical severity, many cases remain undiagnosed or misdiagnosed, suggesting that the true prevalence of Central Core Disease may be higher than current clinical estimates indicate. Is Central Core Disease considered common or rare? Central Core Disease is classified as a rare disease.
What is the prevalence of Central Core Disease?
Prevalence of Central Core Disease: how many people are affected worldwide, differences by sex and region, with sources.
Central Core Disease (CCD) is a rare congenital myopathy with an estimated prevalence of approximately 1 in 90,000 to 1 in 200,000 individuals worldwide. Due to the wide spectrum of clinical severity, many cases remain undiagnosed or misdiagnosed, suggesting that the true prevalence of Central Core Disease may be higher than current clinical estimates indicate.
Is Central Core Disease considered common or rare?
Central Core Disease is classified as a rare disease. Because it is often associated with malignant hyperthermia susceptibility, it is frequently identified only after an adverse reaction to anesthesia, which leads to significant underreporting in standard epidemiological databases. The DiseaseMaps.org community currently supports 89 people with Central Core Disease, providing a vital real-world perspective that complements clinical data by highlighting the lived experience of those navigating this diagnosis.
How does Central Core Disease affect different populations?
The distribution of Central Core Disease shows no significant predilection for specific geographic regions or ethnic groups. Regarding gender and onset, the clinical facts are as follows:
- Gender Distribution: Both males and females are affected equally by Central Core Disease.
- Age of Onset: While typically presenting in infancy or early childhood with hypotonia and delayed motor milestones, some individuals with milder forms of Central Core Disease may not show symptoms until adulthood.
- Incidence Rates: Precise annual incidence rates are difficult to calculate because Central Core Disease often goes unnoticed in asymptomatic carriers who only discover their status through genetic testing or anesthetic complications.
Why is it difficult to track the prevalence of Central Core Disease?
Accurate epidemiological tracking for Central Core Disease is hindered by variable expressivity, where family members with the same genetic mutation may exhibit vastly different symptom severities. Furthermore, because Central Core Disease shares phenotypic overlap with other congenital myopathies, clinical misdiagnosis remains a major barrier to gathering comprehensive global prevalence statistics.
Next steps
- Consult with a neuromuscular specialist or clinical geneticist to confirm a diagnosis through genetic testing, specifically looking for RYR1 gene mutations.
- Join the DiseaseMaps.org community to connect with the 89 other members managing Central Core Disease and share experiences regarding symptom management.
- Request a referral to a center of excellence that specializes in congenital myopathies and malignant hyperthermia protocols.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet: Central Core Disease (ORPHA:206)
- NIH Genetic and Rare Diseases Information Center (GARD): Central Core Disease
- OMIM (Online Mendelian Inheritance in Man): Central Core Disease of Muscle (#117000)
- RYR1 Foundation: Resources for Central Core Disease and related myopathies
